Management ChangeJun 30, 2026, 05:21 PM
Rocket Pharmaceuticals Appoints Joseph Manhede as Principal Accounting Officer
AI Summary
Rocket Pharmaceuticals, Inc. announced the resignation of John Militello as VP of Finance, Senior Controller, Treasurer, and Principal Accounting Officer, effective July 7, 2026. Following this, Joseph Manhede, the company's Associate Vice President, Corporate Controller, has been appointed as the new Principal Accounting Officer, effective July 8, 2026. Mr. Manhede brings extensive experience from various senior finance and accounting roles in the biopharmaceutical industry, including at Outlook Therapeutics and Amneal Pharmaceuticals.
Key Highlights
- John Militello resigned as VP of Finance, Senior Controller, Treasurer, and Principal Accounting Officer.
- Militello's resignation is effective July 7, 2026, to pursue other opportunities.
- Joseph Manhede was appointed as the Company’s Principal Accounting Officer.
- Manhede's appointment is effective July 8, 2026.
- Mr. Manhede has served as Associate Vice President, Corporate Controller since April 2026.
- He previously held senior finance roles at Outlook Therapeutics, Amneal Pharmaceuticals, Unilife Corporation, and Celator Pharmaceuticals.
- No new compensatory arrangements will be entered into with Mr. Manhede for this designation.
Price Impact
More from RCKT